The Federal Trade Commission has given its approval to a final rule that requires healthcare companies to provide more information when they file for mergers and acquisitions. This new requirement is intended to increase transparency and scrutiny in the healthcare sector, reflecting the agency's dedication to ensuring fair competition and protecting consumer interests.

Companies will now have to disclose more comprehensive details about their proposed transactions. This is part of a broader effort by regulators to address concerns about market consolidation and its potential impact on healthcare service pricing and accessibility.

The FTC's decision highlights the growing regulatory focus on the healthcare industry as it deals with significant mergers and acquisitions.